Mandalmed

Developing therapies for fibrosis by modulating glycobiology and innate immunity

placeSan Francisco, California, United States calendar_todayFounded 2000 groups5 employees language mandalmed.com

Innovation

4 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 656 times.

YearFilings
20161
20171
20181
20191
20203
20212
20231

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon